Ionis Pharmaceuticals Inc. (IONS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Ionis Pharmaceuticals Inc...

NASDAQ: IONS · Real-Time Price · USD
63.94
1.37 (2.19%)
At close: Sep 24, 2025, 3:59 PM
64.00
0.09%
After-hours: Sep 24, 2025, 07:49 PM EDT

Ionis Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
705.14M 787.65M 587M 810M
Cost of Revenue
11.21M 9.13M 14M 11M
Gross Profit
693.92M 778.51M 573M 799M
Operating Income
-475.08M -353.73M -411M -30.19M
Interest Income
-6K 89.04M 25.33M 10.04M
Pretax Income
-460.07M -333.96M -258M -29.15M
Net Income
-453.9M -366.29M -270M -28.6M
Selling & General & Admin
267.5M 232.6M 151M 186M
Research & Development
901.53M 899.63M 833M 643M
Other Expenses
-26K 19K n/a n/a
Operating Expenses
1.17B 1.13B 984M 829M
Interest Expense
90.45M 81.46M 8.12M 9.35M
Selling & Marketing Expenses
n/a n/a 700K 15.1M
Cost & Expenses
1.18B 1.14B 998M 840M
Income Tax Expense
-6.17M 32.32M 11.74M -551K
Shares Outstanding (Basic)
149.51M 143M 141.85M 141.02M
Shares Outstanding (Diluted)
149.51M 143.19M 141.85M 141.02M
EPS (Basic)
-3.04 -2.56 -1.9 -0.2
EPS (Diluted)
-3.04 -2.56 -1.9 -0.2
EBITDA
-475.08M -230.01M -227.76M -239K
EBIT
-477.06M -252.51M -249.86M -19.8M
Depreciation & Amortization
1.98M 22.5M 22.11M 19.56M